CME earnings analysis — 8-K, transcript, statement tablesCME Group Inc. (CME) 财报解读 — 8-K、电话会、最新财务报表
1. CME Group Q2 2026 Earnings Follow-Up Analysis
This analysis is anchored to the July 22, 2026 official press release, SEC Form 8-K filing, and Q2 2026 earnings call transcript.
1. Actual vs. Consensus Results: Non-GAAP diluted EPS totaled $2.99, beating the consensus estimate of $2.91 by 2.7%. Total revenue came in at $1.7 billion, matching the Wall Street consensus exactly.
2. Revenue and Profitability Quality: Total revenue declined 9.2% year-over-year, yet represented the second-highest quarterly revenue in company history, trailing only Q1 2026 results. Gross margin hit 69.2%, operating margin reached 64.9%, with operating income falling 15.5% YoY. EBITDA was $834 million with a 48.9% margin, while GAAP diluted EPS was $2.88 and net income totaled $1.0 billion for a 61.1% net margin.
3. Cash Flow and Capital Returns: Operating cash flow reached $1.3 billion, with capital expenditures of $22 million, generating $1.2 billion in free cash flow. As of June 30, 2026, the company held $2.1 billion in cash and equivalents, $3.4 billion in total debt, with net debt of $1.3 billion. The firm returned $1.2 billion to shareholders in Q2, including $468 million in regular quarterly dividends and $695 million in share repurchases.
4. Guidance: No quantitative performance guidance was provided in the disclosed materials, with no public information on whether guidance was raised, lowered, or reaffirmed.
5. GAAP vs. Non-GAAP Reconciliation: The official release and 8-K filing disclosed non-GAAP adjusted operating income, adjusted net income, and adjusted EPS figures, with a reconciliation table available in the SEC 8-K exhibit, though specific reconciling items were not made public.
6. Management Commentary: CEO Terry Duffy noted Q2 2026 average daily volume (ADV) was 29.8 million contracts, the second-highest Q2 ADV on record, with market data revenue up 20% YoY to a record $238 million, and daily client margin efficiencies exceeding $95 billion. Management also outlined upcoming product launches including single-stock futures, 24/7 one-ounce gold trading, and Treasury Link. The CFO added that Q3 2026 volume through July to date was tracking 18% ahead of the prior year period.
7. Unresolved Investor Questions: Segment-specific revenue data, backlog or deferred revenue details, capex allocation plans, product-specific demand and pricing metrics, and formal Q3 2026 quantitative guidance have not been disclosed in the available materials.
一、芝商所（CME Group）2026年第二季度业绩跟踪分析
本次分析基于2026年7月22日发布的官方公告、SEC 8-K文件及季度电话会议纪要。
1. 业绩与预期对比：非GAAP调整后摊薄每股收益（EPS）为2.99美元，超出市场一致预期的2.91美元，超额幅度2.7%；总营收17亿美元，与市场预期完全一致。
2. 盈利质量：本季度总营收同比下滑9.2%，但为史上第二高季度营收（仅次于2026年第一季度）。毛利率69.2%，营业利润率64.9%，营业收入同比下滑15.5%；EBITDA为8.34亿美元，利润率48.9%。GAAP摊薄EPS为2.88美元，净收入10亿美元，净利润率61.1%。
3. 现金流与资本回报：经营现金流13亿美元，资本支出2200万美元，自由现金流12亿美元。截至季末，现金及等价物21亿美元，总债务34亿美元，净债务13亿美元。本季度向股东返还12亿美元，含4.68亿美元季度股息及6.95亿美元股票回购。
4. 业绩指引：本次披露材料未提供任何量化业绩指引，无调整、维持或下调指引的相关信息。
5. GAAP与非GAAP差异：官方披露了非GAAP调整后经营收入、净利润及EPS数据，GAAP与非GAAP的调节表可在SEC 8-K附件中查阅，但未公开具体调节项细节。
6. 管理层评论：CEO Terry Duffy指出本季度ADV为2980万手，为史上第二高Q2成交量，市场数据营收同比增长20%至2.38亿美元创历史新高，客户每日保证金效率提升超950亿美元。管理层还提及多项新产品进展，包括即将推出的单股票期货、24/7盎司黄金交易等；CFO补充称7月迄今的第三季度成交量较去年同期增长18%。
7. 未明确信息：暂未披露细分业务板块营收、订单积压/递延收入、资本支出具体规划、分产品需求与定价细节，以及Q3正式量化业绩指引。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。